Efficacy Comparison of Neoadjuvant Short-Course and Long-Course Radiotherapy Regimens With or Without Immunotherapy for Locally Advanced pMMR Rectal Cancer: A Systematic Review and Network Meta-Analysis - Top-Institutions - MDSpire

Efficacy Comparison of Neoadjuvant Short-Course and Long-Course Radiotherapy Regimens With or Without Immunotherapy for Locally Advanced pMMR Rectal Cancer: A Systematic Review and Network Meta-Analysis

  • By

  • Liqing Li

  • Xiaoyao Meng

  • Qiaoyuan Wu

  • Yuxin Wei

  • Shixiong Liang

  • Tingshi Su

  • March 14, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiation Oncology
    • Colorectal Surgery
    • Medical Oncology
    • Immunotherapy

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Gastrointestinal Oncology
    • Immunotherapy

  • #3

    Dana-Farber Cancer Institute / Brigham and Women’s Hospital
    Dana-Farber Cancer Institute / Brigham and Women’s Hospital

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Radiation Oncology
    • Immunotherapy

  • #4

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Radiation Oncology
    • Colorectal Surgery
    • Immunotherapy

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Surgical Oncology
    • Radiation Oncology
    • Immunotherapy

Original Source(s)

Efficacy Comparison of Neoadjuvant Short-Course and Long-Course Radiotherapy Regimens With or Without Immunotherapy for Locally Advanced pMMR Rectal Cancer: A Systematic Review and Network Meta-Analysis

  • by Liqing Li, Xiaoyao Meng, Qiaoyuan Wu, Yuxin Wei, Shixiong Liang, Tingshi Su

  • March 14, 2026

Related Content

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report